Cargando…
Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients
BACKGROUND: Hematopoietic pre‐B‐cell leukemia transcription factor (PBX)‐interacting protein (HPIP) has shown to be overexpressed in several human cancers. The purpose of this study was to explore the expression of HPIP in endometrial cancer (EC) and its associated effects on disease. METHODS: A tot...
Autores principales: | Cheng, Li, Zhao, Tingting, Li, Shiguo, Wang, Yao, Fei, Hui, Meng, Fanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805295/ https://www.ncbi.nlm.nih.gov/pubmed/31241209 http://dx.doi.org/10.1002/jcla.22959 |
Ejemplares similares
-
The clinical significance of HPIP and the associated prognosis in cervical cancer
por: Meng, Fanling, et al.
Publicado: (2017) -
Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study
por: Wang, Yuping, et al.
Publicado: (2016) -
HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer
por: Cao, Shan, et al.
Publicado: (2017) -
RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
por: Liu, Shuang, et al.
Publicado: (2019) -
A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein
por: Li, Pengyun, et al.
Publicado: (2021)